A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

NCT00357188 ·Status: COMPLETED ·Phase: PHASE1

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

NCT00144105 ·Status: TERMINATED ·Phase: PHASE2

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

NCT00435929 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

NCT00025727 ·Status: UNKNOWN ·Phase: PHASE3

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

NCT02034838 ·Status: COMPLETED ·Phase: PHASE1

A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

NCT00002364 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

NCT00326716 ·Status: COMPLETED ·Phase: PHASE1

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

NCT00440947 ·Status: COMPLETED ·Phase: PHASE3

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

NCT00056641 ·Status: COMPLETED ·Phase: PHASE2

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

NCT00273273 ·Status: COMPLETED

Once-Daily Drug Regimen for HIV-Infected Patients

NCT00001968 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

NCT00838162 ·Status: COMPLETED ·Phase: PHASE2

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

NCT00034866 ·Status: COMPLETED ·Phase: PHASE2

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

NCT00411957 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

NCT00004578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

NCT00357604 ·Status: COMPLETED ·Phase: PHASE1

Atazanavir Twice Daily

NCT00357721 ·Status: COMPLETED ·Phase: PHASE1

Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

NCT00000733 ·Status: COMPLETED ·Phase: PHASE1

Switch to Unboosted Atazanavir With Tenofovir Study

NCT01351740 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301 ·Status: COMPLETED ·Phase: PHASE3

A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

NCT00348673 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients

NCT00647244 ·Status: COMPLETED ·Phase: PHASE4

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

NCT01605084 ·Status: WITHDRAWN ·Phase: PHASE3

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

NCT00028366 ·Status: COMPLETED ·Phase: NA